Grande García, Carlos
European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma. [carta] - Haematologica, 2016 - 101(10):e407-e410.
Formato Vancouver:
Zinzani PL, Karlin L, Radford J, Caballero D, Fields P, Chamuleau ME et al. European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma. Haematologica. 2016 Oct;101(10):e407-e410.
PMID: 27418646
PMC5046662
Contiene 11 referencias
No abstract available
European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma. [carta] - Haematologica, 2016 - 101(10):e407-e410.
Formato Vancouver:
Zinzani PL, Karlin L, Radford J, Caballero D, Fields P, Chamuleau ME et al. European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma. Haematologica. 2016 Oct;101(10):e407-e410.
PMID: 27418646
PMC5046662
Contiene 11 referencias
No abstract available
